Genor Biopharma (06998) Publishes October 2025 Monthly Return with No Change in Issued Share Capital

Bulletin Express

Nov 05

Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s authorized share capital remained at 1,000,000,000 ordinary shares, amounting to USD 20,000. There was no increase or decrease in the total number of issued shares, which ended the month at 528,291,792.

The announcement also detailed multiple share option plans and restricted share unit grants under the company’s share schemes. However, no new shares were issued and no treasury shares were transferred during the reporting period. Warrants and convertibles were not applicable in this return, and the company confirmed that all relevant listing rules and regulatory requirements were met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1109139409"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109139409\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109139409?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 12:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109139409","market":"us","top_or_hot":-1,"title":"Genor Biopharma (06998) Publishes October 2025 Monthly Return with No Change in Issued Share Capital","media":"Bulletin Express","content":"<p>Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s authorized share capital remained at 1,000,000,000 ordinary shares, amounting to USD 20,000. There was no increase or decrease in the total number of issued shares, which ended the month at 528,291,792.</p>\n<p>The announcement also detailed multiple share option plans and restricted share unit grants under the company’s share schemes. However, no new shares were issued and no treasury shares were transferred during the reporting period. Warrants and convertibles were not applicable in this return, and the company confirmed that all relevant listing rules and regulatory requirements were met.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genor Biopharma (06998) Publishes October 2025 Monthly Return with No Change in Issued Share Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenor Biopharma (06998) Publishes October 2025 Monthly Return with No Change in Issued Share Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 12:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s authorized share capital remained at 1,000,000,000 ordinary shares, amounting to USD 20,000. There was no increase or decrease in the total number of issued shares, which ended the month at 528,291,792.</p>\n<p>The announcement also detailed multiple share option plans and restricted share unit grants under the company’s share schemes. However, no new shares were issued and no treasury shares were transferred during the reporting period. Warrants and convertibles were not applicable in this return, and the company confirmed that all relevant listing rules and regulatory requirements were met.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物-B","start_time":0,"source_url":"","article_id":"1109139409","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109139409","pubTimestamp":1762315391,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物-B"},"translate_title":"嘉和生物(06998)公布2025年10月已发行股本无变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s authorized share capital remained at 1,000,000,000 ordinary shares, amounting to USD 20,000. There was no increase or decrease in the total number of issued shares, which ended the month at 528,291,792.\nThe announcement also detailed multiple share option plans and restricted share unit grants under the company’s share schemes. However, no new shares were issued and no treasury shares were transferred during the reporting period. Warrants and convertibles were not applicable in this return, and the company confirmed that all relevant listing rules and regulatory requirements were met.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}